BioCentury
ARTICLE | Financial News

Caladrius Biosciences completes direct public offering

September 19, 2016 7:00 AM UTC

Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Business: Gene/Cell therapy, Cardiovascular, Endocrine/Metabolic Date completed: 2016-09-15 Type: Direct public offering Raised: $4 million Sha...